The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1 von Wylie, Andrew A., Schoepfer, Joseph, Jahnke, Wolfgang, Cowan-Jacob, Sandra W., Loo, Alice, Furet, Pascal, Marzinzik, Andreas L., Pelle, Xavier, Donovan, Jerry, Zhu, Wenjing, Buonamici, Silvia, Hassan, A. Quamrul, Lombardo, Franco, Iyer, Varsha, Palmer, Michael, Berellini, Giuliano, Dodd, Stephanie, Thohan, Sanjeev, Bitter, Hans, Branford, Susan, Ross, David M., Hughes, Timothy P., Petruzzelli, Lilli, Vanasse, K. Gary, Warmuth, Markus, Hofmann, Francesco, Keen, Nicholas J., Sellers, William R.

Volltext

Persistence of myelofibrosis treated with ruxolitinib: biology and clinical implications von Ross, David M, Babon, Jeffrey J, Tvorogov, Denis, Thomas, Daniel

Volltext

Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia von Nwosu, Gus O., Ross, David M., Powell, Jason A., Pitson, Stuart M.

Volltext

Platelets from patients with myeloproliferative neoplasms have increased numbers of mitochondria that are hypersensitive to depolarization by thrombin von Ross, David M., Liang, Hai Po Helena, Iqra, Zeenet, Whittaker, Shane, Tan, Chuen Wen, Dale, Brian J., Chen, Vivien M.

Volltext

Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome von Singhal, Deepak, Kutyna, Monika M, Chhetri, Rakchha, Wee, Li Yan A, Hague, Sophia, Nath, Lakshmi, Nath, Shriram V, Sinha, Romi, Wickham, Nicholas, Lewis, Ian D, Ross, David M, Bardy, Peter G, To, Luen Bik, Reynolds, John, Wood, Erica M, Roxby, David J, Hiwase, Devendra K

Volltext

Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention von Shanmuganathan, Naranie, Wadham, Carol, Shahrin, NurHezrin, Feng, Jinghua, Thomson, Daniel, Wang, Paul, Saunders, Verity, Kok, Chung Hoow, King, Rob M, Kenyon, Rosalie R, Lin, Ming, Pagani, Ilaria S, Ross, David M, Yong, Agnes S M, Grigg, Andrew P, Mills, Anthony K, Schwarer, Anthony P, Braley, Jodi, Altamura, Haley, Yeung, David T, Scott, Hamish S, Schreiber, Andreas W, Hughes, Timothy P, Branford, Susan

Volltext

BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia von Pagani, Ilaria S, Dang, Phuong, Kommers, Ivar O, Goyne, Jarrad M, Nicola, Mario, Saunders, Verity A, Braley, Jody, White, Deborah L, Yeung, David T, Branford, Susan, Hughes, Timothy P, Ross, David M

Volltext

Single cells tell multiple tales in CML von Ross, David M.

Volltext

Moving treatment-free remission into mainstream clinical practice in CML von Hughes, Timothy P., Ross, David M.

Volltext

Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia von Bassal, Mahmoud A., Samaraweera, Saumya E., Lim, Kelly, Benard, Brooks A., Bailey, Sheree, Kaur, Satinder, Leo, Paul, Toubia, John, Thompson-Peach, Chloe, Nguyen, Tran, Maung, Kyaw Ze Ya, Casolari, Debora A., Iarossi, Diana G., Pagani, Ilaria S., Powell, Jason, Pitson, Stuart, Natera, Siria, Roessner, Ute, Lewis, Ian D., Brown, Anna L., Tenen, Daniel G., Robinson, Nirmal, Ross, David M., Majeti, Ravindra, Gonda, Thomas J., Thomas, Daniel, D’Andrea, Richard J.

Volltext

Iron chelation for myelofibrosis‐related anaemia during treatment with a Janus kinase inhibitor von Ross, David M.

Volltext

Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax von Nguyen, Thao M, Joyce, Paul, Ross, David M, Bremmell, Kristen, Jambhrunkar, Manasi, Wong, Sook S, Prestidge, Clive A

Volltext

How much imatinib is enough? von Ross, David M.

Volltext

Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia von Bassal, Mahmoud A., Samaraweera, Saumya E., Lim, Kelly, Benard, Brooks A., Bailey, Sheree, Kaur, Satinder, Leo, Paul, Toubia, John, Thompson-Peach, Chloe, Nguyen, Tran, Maung, Kyaw Ze Ya, Casolari, Debora A., Iarossi, Diana G., Pagani, Ilaria S., Powell, Jason, Pitson, Stuart, Natera, Siria, Roessner, Ute, Lewis, Ian D., Brown, Anna L., Tenen, Daniel G., Robinson, Nirmal, Ross, David M., Majeti, Ravindra, Gonda, Thomas J., Thomas, Daniel, D’Andrea, Richard J.

Volltext

Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients von Alcheikh, Ahmad, Perkins, Griffith B., Pucar, Phillippa A., Cecchin, Amelia, Chai, Cheng Sheng, Tunbridge, Matthew, Akerman, Anouschka, Aggarwal, Anupriya, Milogiannakis, Vanessa, Turville, Stuart, Allen, Sharon, Hissaria, Pravin, Banovic, Tatjana, Coates, P. Toby, Ross, David M.

Volltext

Treatment-free remission in patients with chronic myeloid leukaemia von Ross, David M., Hughes, Timothy P.

Volltext

Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies von Mesa, Ruben A., Hudgens, Stacie, Floden, Lysbeth, Harrison, Claire N., Palmer, Jeanne, Gupta, Vikas, McLornan, Donal P., McMullin, Mary F., Kiladjian, Jean‐Jaques, Foltz, Lynda, Platzbecker, Uwe, Fox, M. Laura, Mead, Adam J., Ross, David M., Oh, Stephen T., Perkins, Andrew, Leahy, Michael F., Deheshi, Samineh, Donahue, Rafe, Klencke, Barbara J., Verstovsek, Srdan

Volltext

Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia von Duncavage, Eric J., Bagg, Adam, Hasserjian, Robert P., DiNardo, Courtney D., Godley, Lucy A., Iacobucci, Ilaria, Jaiswal, Siddhartha, Malcovati, Luca, Vannucchi, Alessandro M., Patel, Keyur P., Arber, Daniel A., Arcila, Maria E., Bejar, Rafael, Berliner, Nancy, Borowitz, Michael J., Branford, Susan, Brown, Anna L., Cargo, Catherine A., Döhner, Hartmut, Falini, Brunangelo, Garcia-Manero, Guillermo, Haferlach, Torsten, Hellström-Lindberg, Eva, Kim, Annette S., Klco, Jeffery M., Komrokji, Rami, Lee-Cheun Loh, Mignon, Loghavi, Sanam, Mullighan, Charles G., Ogawa, Seishi, Orazi, Attilio, Papaemmanuil, Elli, Reiter, Andreas, Ross, David M., Savona, Michael, Shimamura, Akiko, Skoda, Radek C., Solé, Francesc, Stone, Richard M., Tefferi, Ayalew, Walter, Matthew J., Wu, David, Ebert, Benjamin L., Cazzola, Mario

Volltext

Incidence of blast phase in myelofibrosis according to anemia severity von Mora, Barbara, Maffioli, Margherita, Rumi, Elisa, Guglielmelli, Paola, Caramella, Marianna, Kuykendall, Andrew, Palandri, Francesca, Iurlo, Alessandra, De Stefano, Valerio, Kiladjian, Jean‐Jacques, Elli, Elena M., Polverelli, Nicola, Gotlib, Jason, Albano, Francesco, Silver, Richard T., Benevolo, Giulia, Ross, David M., Devos, Timothy, Borsani, Oscar, Barbui, Tiziano, Porta, Matteo G. Della, Bertù, Lorenza, Komrokji, Rami, Vannucchi, Alessandro M., Passamonti, Francesco

Volltext

Accumulation of JAK activation loop phosphorylation is linked to type I JAK inhibitor withdrawal syndrome in myelofibrosis von Tvorogov, Denis, Thomas, Daniel, Liau, Nicholas P D, Dottore, Mara, Barry, Emma F, Lathi, Maya, Kan, Winnie L, Hercus, Timothy R, Stomski, Frank, Hughes, Timothy P, Tergaonkar, Vinay, Parker, Michael W, Ross, David M, Majeti, Ravindra, Babon, Jeffrey J, Lopez, Angel F

Volltext